Pharmaceutical News

RSS
FDA warns pharmacies to stop mass-producing unapproved inhalation drugs

FDA warns pharmacies to stop mass-producing unapproved inhalation drugs

Dodgy Chinese antibiotic kills at least 7

Dodgy Chinese antibiotic kills at least 7

FDA approves generic version of Effexor (venlafaxine)

FDA approves generic version of Effexor (venlafaxine)

Experimental drug trial victim has cancer

Experimental drug trial victim has cancer

Chinese antibiotic suspected of being a killer jab

Chinese antibiotic suspected of being a killer jab

Implications of the new Medicare Part D prescription drug benefit for people with HIV/AIDS

Implications of the new Medicare Part D prescription drug benefit for people with HIV/AIDS

Plan B or not to be: that is the question!

Plan B or not to be: that is the question!

Darunavir - first molecule to treat drug-resistant HIV

Darunavir - first molecule to treat drug-resistant HIV

FDA approves next seasons flu vaccines

FDA approves next seasons flu vaccines

Timing of FDA Plan B announcement questioned

Timing of FDA Plan B announcement questioned

FDA approves Keppra (levetiracetam) for epilepsy treatment

FDA approves Keppra (levetiracetam) for epilepsy treatment

Doctors say HPV vaccine should be given to everyone

Doctors say HPV vaccine should be given to everyone

FDA does an about turn on Plan B contraceptive pills

FDA does an about turn on Plan B contraceptive pills

Smart cancer drug on sale in the UK

Smart cancer drug on sale in the UK

HHS to stockpile Anthrax immune globulin

HHS to stockpile Anthrax immune globulin

FDA warns against use of high-strength hydrogen peroxide to treat serious diseases

FDA warns against use of high-strength hydrogen peroxide to treat serious diseases

New sunscreen protects against both UVA and UVB rays

New sunscreen protects against both UVA and UVB rays

New bird flu vaccine has 80% protection rate

New bird flu vaccine has 80% protection rate

Remicade receives European approval for treatment of psoriatic arthritis

Remicade receives European approval for treatment of psoriatic arthritis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.